Leaderboards/Lymphatic System and Diseases

Lymphatic System and Diseases

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Lincoln Biswas
Nanyang Technological University
2
Mads Gustaf Jørgensen
University of Southern Denmark
3
Julianne Lundanes
Norwegian University of Science and Technology
4
Maria M. Steele
New York University
5
Consensus
Unknown
6
Lígia Simões Braga Boisserand
Yale University
7
Noelle Leary
Massachusetts Institute of Technology
8
Kristofor Glinton
Renal Research Institute
9
Yangkang Zheng
Shanghai Jiao Tong University
10
Johanna Falck
Jönköping University

Papers

1
Publication in Lymphology (2024) [79 citations, W4401944900]
Lymphology|2024
79 cit.
2
Lymphatic platelet thrombosis limits bone repair by precluding lymphatic transporting DAMPs
Nature Communications|2025
17 cit.
3
Publication in Journal of Orthopaedic Translation (2024) [11 citations, W4392742503]
Journal of Orthopaedic Translation|2024
11 cit.
4
No Clinical Efficacy of Adipose-Derived Regenerative Cells and Lipotransfer in Breast Cancer–Related Lymphedema: A Double-Blind Placebo-Controlled Phase II Trial
Plastic & Reconstructive Surgery|2024
4 cit.
5
Publication in Thrombosis Journal (2024) [3 citations, W4400507960]
Thrombosis Journal|2024
3 cit.
6
Publication in Cancer Research (2024) [W4393987833]
Cancer Research|2024
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Nele Devoogdt
University of Antwerp
2
Sha Wu
Sinovac Biotech
3
Michael T. Dellinger
The University of Texas Southwestern Medical Center
4
Diana Adams
Camden and Campbelltown Hospitals
5
Amanda W. Lund
New York University
6
Lothar C. Dieterich
Heidelberg University
7
Martina Markes
Institute for Quality and Efficiency in Health Care
8
Maria A.S. Broggi
AstraZeneca (Japan)
9
Nicola Fusco
University of Milan
10
Nana Yamamoto
National Center for Global Health and Medicine

Papers

1
Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes
Journal of Extracellular Vesicles|2022
125 cit.
2
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
Nature Immunology|2023
119 cit.
3
Infection-induced lymphatic zippering restricts fluid transport and viral dissemination from skin
The Journal of Experimental Medicine|2022
51 cit.
4
Manual lymphatic drainage with or without fluoroscopy guidance did not substantially improve the effect of decongestive lymphatic therapy in people with breast cancer-related lymphoedema (EFforT-BCRL trial): a multicentre randomised trial
Journal of physiotherapy|2022
44 cit.
5
Improving HER2 testing reproducibility in HER2-low breast cancer
Cancer Drug Resistance|2022
41 cit.
6
Indocyanine Green Lymphography for Evaluation of Breast Lymphedema Secondary to Breast Cancer Treatments
Journal of Reconstructive Microsurgery|2022
29 cit.
7
Standard operating procedures for biobank in oncology
Frontiers in Molecular Biosciences|2022
26 cit.
8
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
European Journal of Cancer|2025
24 cit.
9
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer
Cells|2022
23 cit.
10
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
International Journal of Molecular Sciences|2024
21 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Kari Alitalo
University of Helsinki
2
Michael Detmar
Harvard University
3
George D. Yancopoulos
Regeneron (United States)
4
Donald M. McDonald
UCSF Helen Diller Family Comprehensive Cancer Center
5
Guillermo Oliver
Northwestern University
6
Melody A. Swartz
University of Chicago
7
Isao Koshima
Hiroshima University Hospital
8
Babak J. Mehrara
Memorial Sloan Kettering Cancer Center
9
Peter Mortimer
St George's, University of London
10
David G. Jackson
Huazhong Agricultural University

Papers

1
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Science|1997
3.6k cit.
2
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Cell|1996
2.9k cit.
3
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
Nature Cell Biology|2001
2.7k cit.
4
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
The Journal of Experimental Medicine|2015
2.2k cit.
5
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Cell|1996
2k cit.
6
ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
Cell|1991
1.9k cit.
7
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
New England Journal of Medicine|2020
1.8k cit.
8
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Nature Medicine|2001
1.7k cit.
9
A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases.
The EMBO Journal|1996
1.7k cit.
10
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
American Journal Of Pathology|2000
1.7k cit.

Reagents for Lymphatic System and Diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Phospho-EphA2 (Tyr588) (D7X2L) Rabbit Monoclonal Antibody

Cited in 11 papers
#12677$178,412
View Evidence →
Cell Signaling Technology

Max (S20) Antibody

Cited in 10 papers
#4739$317
View Evidence →
Cell Signaling TechnologyEvidence 62

Filamin A Antibody

Cited in 9 papers
#4762$317
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

D2-40

Cited in 29 papers
#M3619
View Evidence →
AbcamEvidence 60

LYVE1 antibody - Lymphatic Vessel Marker

Cited in 18 papers
#ab14917
View Evidence →
R&D Systems

Human Prox1 Antibody

Cited in 13 papers
#AF2727 (also AF2727-SP)
View Evidence →